Fecal transplant trial for worsening liver failure
Treatments studied
Part of Digestive system clinical trials.
This trial studies fecal microbiota transplantation (a transfer of healthy gut bacteria from a donor) to help people with worsening liver failure. It may help by changing gut bacteria, which can affect complications like confusion, fluid buildup, infections, and kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 65 years old
- A doctor has diagnosed you with liver failure based on the study’s criteria (rapidly worsening yellowing plus blood clotting problems and/or specific blood test levels)
- You can and will sign informed consent
- You do NOT have certain serious conditions (for example severe heart failure, serious lung disease like COPD, or prior stroke)
- You do NOT have active serious infections or certain bleeding (for example gastrointestinal bleeding or septicemia)
- You do NOT have known cancer, and you are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether transferring healthy gut bacteria (from a donor sample) can improve outcomes for people with liver cirrhosis who have worsening complications. It may help by changing the gut microbiome, which can influence inflammation and liver health.
This study tests whether stool from healthy donors can help people with advanced liver disease (cirrhosis) who have had complications like fluid buildup. You would receive the transplant through a colonoscopy or enema.
This trial tests whether transplanting healthy gut bacteria (from donor stool) can improve outcomes in people with cirrhosis. If you have mild to moderate cirrhosis, you may be able to join.
This trial tests whether a fecal microbiota transplant (FMT) can help overcome drug resistance in people with advanced liver cancer whose disease has worsened after a specific triple therapy (TACE, lenvatinib, and sintilimab). FMT involves transferring gut bacteria from a healthy donor to restore the balance of your gut microbiome, which may make your cancer more responsive to treatment again.
This trial tests whether fecal microbiota transplantation (a controlled transfer of stool bacteria) is safe in people with severe alcoholic hepatitis. It aims to see if the treatment is tolerable and what risks may come with it, in addition to watching how liver illness changes.
This trial tests if transferring healthy bacteria into your gut (fecal microbiota transplant) can help people who still get confusion episodes (hepatic encephalopathy) even after a TIPS procedure and while on standard medications like lactulose and rifaximin.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.